These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7667104)

  • 1. Calreticulin inhibits vitamin D3 signal transduction.
    Wheeler DG; Horsford J; Michalak M; White JH; Hendy GN
    Nucleic Acids Res; 1995 Aug; 23(16):3268-74. PubMed ID: 7667104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimers.
    Winrow CJ; Miyata KS; Marcus SL; Burns K; Michalak M; Capone JP; Rachubinski RA
    Mol Cell Endocrinol; 1995 Jun; 111(2):175-9. PubMed ID: 7556879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
    Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
    Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.
    Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
    Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor.
    Jurutka PW; MacDonald PN; Nakajima S; Hsieh JC; Thompson PD; Whitfield GK; Galligan MA; Haussler CA; Haussler MR
    J Cell Biochem; 2002; 85(2):435-57. PubMed ID: 11948698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin.
    Shago M; Flock G; Leung Hagesteijn CY; Woodside M; Grinstein S; Giguère V; Dedhar S
    Exp Cell Res; 1997 Jan; 230(1):50-60. PubMed ID: 9013706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
    Alroy I; Towers TL; Freedman LP
    Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
    Lemon BD; Freedman LP
    Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid.
    Garcia-Villalba P; Jimenez-Lara AM; Aranda A
    Mol Cell Biol; 1996 Jan; 16(1):318-27. PubMed ID: 8524311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
    Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
    Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of calreticulin in osteoblasts inhibits mineralization.
    St-Arnaud R; Prud'homme J; Leung-Hagesteijn C; Dedhar S
    J Cell Biol; 1995 Dec; 131(5):1351-9. PubMed ID: 8522595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.